| Q39690103 | A 5-year prospective study of predictors for disability pension among patients with major depressive disorder. |
| Q91760395 | A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder |
| Q54957701 | A Cross-sectional Analysis of Patterns and Predictors of Medication Adherence in Bipolar Disorder: Single Center Experience from South India. |
| Q35851118 | A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences |
| Q35947326 | A collaborative approach to the treatment alliance in bipolar disorder |
| Q44970775 | A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. |
| Q37632466 | A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder |
| Q35743464 | A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis |
| Q39671780 | ANTIDEPRESSANT ADHERENCE ACROSS DIVERSE POPULATIONS AND HEALTHCARE SETTINGS. |
| Q89268927 | Adaptation and validation of the "tolerability and quality of life" (TOOL) questionnaire in Chinese bipolar patients |
| Q38668405 | Adherence to Antipsychotic Medication and Criminal Recidivism in a Canadian Provincial Offender Population. |
| Q38852539 | Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review |
| Q41894282 | Adherence to antidepressant medications: an evaluation of community pharmacists' counseling practices |
| Q36691765 | Adherence to antidepressant treatment |
| Q44671658 | Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study |
| Q40175775 | Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment |
| Q37619620 | Adherence to medication in the community: audit cycle of interventions to improve the assessment of adherence |
| Q35673084 | Adherence to treatment for geriatric depression and anxiety |
| Q35570854 | Adherence with general healthcare among internal medicine outpatients with mental health treatment histories. |
| Q33906501 | Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals |
| Q79832852 | Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder |
| Q33451382 | An Open Trial of a Smartphone-assisted, Adjunctive Intervention to Improve Treatment Adherence in Bipolar Disorder |
| Q34433880 | Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity |
| Q37429700 | Antidepressant medication adherence: a study of primary care patients |
| Q33582832 | Antidepressant utilization after hospitalization with depression: a comparison between non-Western immigrants and Danish-born residents |
| Q37661052 | Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey |
| Q47902055 | Assessing Cognitive Representations of Antidepressants: Development and Validation of the Attitudes Toward Medication-Depression Inventory |
| Q36672376 | Assessment of medication management ability in middle-aged and older adults with bipolar disorder |
| Q64119019 | Association Between Medication Adherence and Oxidative Stress in Patients With First-Episode Mania |
| Q37415124 | Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder |
| Q47651644 | Associations of Comorbid Anxiety With Medication Adherence and Psychiatric Symptomatology in a Population of Nonadherent Bipolar Disorder Subjects |
| Q34691370 | Attitudes and beliefs among patients treated with mood stabilizers |
| Q82620346 | Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment |
| Q33797383 | Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study. |
| Q40183011 | Beliefs about antidepressant medication and associated adherence among older Chinese patients with major depression: A cross-sectional survey |
| Q44798199 | Benefits of consumer psychoeducation: a pilot program in South Africa |
| Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
| Q24198292 | Collaborative care for depression and anxiety problems |
| Q24246111 | Collaborative care for depression and anxiety problems |
| Q33490837 | Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol |
| Q34430833 | Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illness |
| Q35212332 | Concepts in the treatment of bipolar disorder. |
| Q39490151 | Connection between self-stigma, adherence to treatment, and discontinuation of medication |
| Q36140331 | Contemporary Approaches to Frequent Mood Monitoring in Bipolar Disorder |
| Q47312453 | Contributions of community pharmacists to patients on antidepressants-a qualitative study among key informants |
| Q64112189 | Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy |
| Q34777367 | Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder |
| Q46713324 | Current management of bipolar affective disorder: is it reflective of the BAP guidelines? |
| Q36905876 | Depot antipsychotic medications in bipolar disorder: a review of the literature |
| Q37350371 | Depression Treatment Non-adherence and its Psychosocial Predictors: Differences between Young and Older Adults? |
| Q40599522 | Depression requiring anti-depressant drug therapy in adult congenital heart disease: prevalence, risk factors, and prognostic value. |
| Q42863118 | Depression should be managed like a chronic disease |
| Q48906947 | Depression treatment preferences among Japanese undergraduates: using conjoint analysis |
| Q44594822 | Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR). |
| Q57453024 | Determinants of suboptimal medication adherence in patients with a major depressive episode |
| Q46951696 | Determination of blood concentration levels of psychotropic medications in Rwandan patients |
| Q51938739 | Development of an antidepressant compliance questionnaire. |
| Q42529784 | Diagnosis and management of patients with bipolar disorder in primary care. |
| Q37160021 | Discontinuation of antidepressant medication among Latinos in the USA. |
| Q36058906 | Do antidepressants reduce the burden imposed by depression on employers? |
| Q51903837 | Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets. |
| Q44919994 | Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users? |
| Q30878126 | Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data |
| Q43443984 | Economic factors in of patients' nonadherence to antidepressant treatment |
| Q37919176 | Effectiveness of interventions to improve antidepressant medication adherence: a systematic review |
| Q36458087 | Effectiveness of specific intervention on treatment adherence of persons with mental illness: A pilot study |
| Q90088544 | Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence |
| Q44626923 | Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners |
| Q35963098 | Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? |
| Q37664710 | Enhancing medication adherence in patients with bipolar disorder |
| Q34064341 | Enhancing medication adherence: in older adults with bipolar disorder |
| Q91276162 | Ethnopsychopharmacology study of patients' beliefs regarding concerns about and necessity of taking psychiatric medications |
| Q36128887 | Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. |
| Q53778441 | Evaluation of the Effectiveness of a Psychoeducational Intervention in Treatment-Naïve Patients with Antidepressant Medication in Primary Care: A Randomized Controlled Trial. |
| Q34676317 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology |
| Q35180787 | Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology |
| Q37426143 | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology |
| Q36327267 | Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review |
| Q47923350 | Experience of Psychotropic Medication -An Interview Study of Persons with Psychosis |
| Q50584707 | Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence. |
| Q37403751 | Factors Affecting Non-Adherence among Patients Diagnosed with Unipolar Depression in a Psychiatric Department of a Tertiary Hospital in Kolkata, India |
| Q38064456 | Factors associated with antidepressant medication adherence and adherence-enhancement programmes: a systematic literature review |
| Q40146888 | Factors associated with treatment nonadherence among US bipolar disorder patients |
| Q37735808 | Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach |
| Q33864817 | Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study |
| Q44961117 | Health care providers' perspectives of medication adherence in the treatment of depression: a qualitative study |
| Q46104148 | High-dose desvenlafaxine in outpatients with major depressive disorder |
| Q41017263 | How to Improve Adherence to Medication and Follow-up in Chronic Mental Illnesses: Stakeholder Views |
| Q37405496 | Identification of primary care patients at risk of nonadherence to antidepressant treatment |
| Q36286408 | Identifying and improving non-adherence in bipolar disorders. |
| Q35119770 | Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication |
| Q93345907 | Impact of preexisting mental illness on breast cancer endocrine therapy adherence |
| Q36797182 | Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial |
| Q37546078 | Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk |
| Q36514282 | Improving compliance in depression: a systematic review of narrative reviews |
| Q33952577 | Improving quality of depression care using organized systems of care: a review of the literature |
| Q36951439 | Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development |
| Q34767177 | Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach |
| Q48086104 | In depression, increased psychological reactance is associated with poorer treatment compliance |
| Q37079329 | Influence of psychotherapy attendance on buprenorphine treatment outcome. |
| Q37069910 | Initiation of antidepressant therapy: do patients follow the GP's prescription? |
| Q43989536 | Integrated management of major depression for people with cancer |
| Q92536267 | Integrating Patients' Expectations into the Management of Their Depression: Report of a Symposium at the European College of Neuropsychopharmacology Congress |
| Q38708073 | Internet- and mobile-based aftercare and follow-up for mental disorders: protocol of a systematic review and meta-analysis |
| Q90232708 | Internet- and mobile-based aftercare and relapse prevention in mental disorders: A systematic review and recommendations for future research |
| Q36029019 | Is Customization in Antidepressant Prescribing Associated with Acute-Phase Treatment Adherence? |
| Q54353511 | Is case-finding an inefficient way of addressing depression as a public health problem? |
| Q35212737 | Issues in the treatment of bipolar disorder |
| Q34267385 | Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder |
| Q54217848 | Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications. |
| Q36896525 | Maximizing treatment outcomes in the depressed patient. |
| Q37594717 | Measurement of psychiatric treatment adherence |
| Q48889319 | Mediating roles of adherence attitude and patient education on antidepressant use in patients with depression |
| Q64078180 | Medication Adherence Using Electronic Monitoring in Severe Psychiatric Illness: 4 and 24 Weeks after Discharge |
| Q38902384 | Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. |
| Q37071075 | Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic |
| Q37684910 | Medication adherence in a comparative effectiveness trial for bipolar disorder. |
| Q44133367 | Medication adherence of individuals with a first episode of psychosis |
| Q45251682 | Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers |
| Q64321080 | Medication nonadherence in bipolar disorder: a narrative review |
| Q56456125 | Medication therapy: adherence, knowledge and difficulties of elderly people from bipolar disorder |
| Q37239332 | Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder |
| Q27314831 | Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness |
| Q38125217 | Mood disorders medications: predictors of nonadherence - review of the current literature |
| Q35866209 | Motivational pharmacotherapy: combining motivational interviewing and antidepressant therapy to improve treatment adherence |
| Q41616576 | Neuropsychological functioning, age, and medication adherence in bipolar disorder |
| Q42931486 | No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations |
| Q37380093 | Non-Compliance and Related Factors in Patients With Bipolar I Disorder: A Six Month Follow-Up Study |
| Q51958126 | Non-adherence in psychiatric disorders: misbehaviour or clinical feature? |
| Q39880242 | Non-adherence with psychotropic medications in the general population |
| Q98287894 | Nonadherence in bipolar disorder patients: A 14-year retrospective study |
| Q33746806 | Noncontinuous use of antidepressant in adults with major depressive disorders - a retrospective cohort study. |
| Q52646032 | Novel treatment options in depression and psychosis. |
| Q38059360 | Nutrient-based therapies for bipolar disorder: a systematic review |
| Q89665767 | Optimizing Adherence: Bipolar Disorder and the Therapeutic Motivational Alliance |
| Q42252223 | Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection |
| Q58034108 | Patient-Centered Perspectives on Antidepressant Use |
| Q39372403 | Patients' perceptions of barriers to self-managing bipolar disorder: A qualitative study |
| Q51873163 | Perceived access to general medical and psychiatric care among veterans with bipolar disorder. |
| Q37445644 | Perceived symptom targets of antidepressants, anxiolytics, and sedatives: the search for modifiable factors that improve adherence. |
| Q36052831 | Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications |
| Q48003871 | Playing With Antidepressants: Perspectives From Indian Australians and Anglo-Australians Living With Depression |
| Q43841386 | Post-inpatient attrition from care "as usual" in veterans with multiple psychiatric admissions |
| Q58436269 | Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention |
| Q47339246 | Predictors of long-term work disability in Major Depressive Disorder: a prospective study |
| Q46927912 | Predictors of medication adherence in patients with schizophrenia and bipolar disorder |
| Q48841890 | Predictors of rehospitalization in high-utilizing patients in the VA psychiatric medical system |
| Q37178704 | Predictors of treatment utilization in major depression |
| Q34082632 | Preserve and strengthen family to promote mental health |
| Q44058174 | Prevalence and factors associated with medication compliance in Indian patients suffering from mental disorders |
| Q36042870 | Prevalence and predictors of sub-optimal medication adherence among patients with severe mental illnesses in a tertiary psychiatric facility in Maiduguri, North-eastern Nigeria |
| Q47739325 | Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention. |
| Q90249291 | Psycho-demographic and clinical predictors of medication adherence in patients with bipolar I disorder in a university hospital in Egypt |
| Q35630083 | Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update |
| Q35236962 | Psychosocial interventions and medication adherence in bipolar disorder |
| Q35569720 | Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review |
| Q30961525 | Quality of life in patients with bipolar I depression: data from 920 patients |
| Q37147173 | Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder |
| Q38073103 | Review of community pharmacy staff educational needs for supporting mental health consumers and carers |
| Q37776074 | Review: The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission |
| Q34314633 | Risk factors for medication non-adherence among psychiatric patients with substance misuse histories. |
| Q51872425 | Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. |
| Q37803220 | Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder |
| Q37756971 | Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder |
| Q33755661 | Role of extended release quetiapine in the management of bipolar disorders |
| Q51921655 | Satisfaction with treatment among patients with depressive and bipolar disorders. |
| Q38061522 | Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin |
| Q35930169 | Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder |
| Q36248072 | Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder |
| Q38223376 | Tackling nonadherence in psychiatric disorders: current opinion |
| Q52305625 | Taking or not taking medications: psychiatric treatment perceptions in patients diagnosed with bipolar disorder. |
| Q35536685 | The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia |
| Q37709437 | The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments. |
| Q39672965 | The acceptability of psychotropic vs. other medications among a small urban primary care sample |
| Q51872462 | The association between depressive symptoms and acute exacerbations of COPD. |
| Q38981605 | The effect of temperament on the treatment adherence of bipolar disorder type I. |
| Q51912719 | The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. |
| Q40817256 | The impact of age and gender on adherence to antidepressants: a 4-year population-based cohort study |
| Q92912415 | The impact of lifestyle Physical Activity Counselling in IN-PATients with major depressive disorders on physical activity, cardiorespiratory fitness, depression, and cardiovascular health risk markers: study protocol for a randomized controlled tria |
| Q35641722 | The impact of psychiatric diagnosis on treatment adherence and duration among victimized children and adolescents in São Paulo, Brazil |
| Q36128822 | The management of bipolar disorder in primary care: a review of existing and emerging therapies |
| Q36099941 | The relationship of antidepressant prescribing concentration to treatment duration and cost |
| Q35157526 | The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder |
| Q41813300 | The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder |
| Q35939680 | The role of paliperidone extended release for the treatment of bipolar disorder |
| Q37395546 | Time to lack of persistence with pharmacological treatment among patients with current depressive episodes: a natural study with 1-year follow-up |
| Q41306174 | Toward a cultural adaptation of pharmacotherapy: Latino views of depression and antidepressant therapy |
| Q35205435 | Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients |
| Q60532531 | Trastorno bipolar: ¿qué efecto tiene el cumplimiento terapéutico en el riesgo de conductas suicidas? |
| Q44083784 | Treatment adherence with antipsychotic medications in bipolar disorder |
| Q58690945 | Treatment alliance and adherence in bipolar disorder |
| Q39080703 | Treatment-adherence in bipolar disorder: A patient-centred approach |
| Q50652770 | Trust, deals and authority: community mental health professionals' experiences of influencing reluctant patients. |
| Q43719617 | Understanding treatment adherence in affective disorders: a qualitative study |
| Q26738513 | Unmet needs of bipolar disorder patients |
| Q38093728 | Use of asenapine in clinical practice for the management of bipolar mania |
| Q35906540 | Use of automated medication adherence monitoring in bipolar disorder research: pitfalls, pragmatics, and possibilities |
| Q92241636 | Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study |
| Q38753620 | Valued Living and Its Relationship to Medication Adherence in Patients with Bipolar and Comorbid Substance Use Disorders |
| Q48545472 | What is the best sequential treatment strategy in the treatment of depression? Adding pharmacotherapy to psychotherapy or vice versa? |
| Q47236837 | What made me feel better? Patients' own explanations for the improvement of their depression |
| Q39806555 | Why do persons with bipolar disorder stop their medication? |
| Q43751280 | Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey |
| Q36558654 | Ziprasidone: efficacy and safety in patients with bipolar disorder |